Interleukin-18: An independent predictor of cardiovascular events in patients with acute coronary syndrome after 6 months of follow-up

Coronary Artery Disease

Volumn 20, Issue 5, 2009, Pages 327-331

  Furtado, Mariana Vargas ^a,b   Rossini, Ana Paula Webber ^b   Campani, Raquel Barth ^b   Meotti, Carolina ^b   Segatto, Majorie ^b   Vietta, Giovanna ^a   Polanczyk, Carísi Anne ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Acute myocardial infarction; C reactive protein; Cytokines; Inflammation; Prognosis; Unstable angina

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 18; TROPONIN T;

ACUTE CORONARY SYNDROME; AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL EXAMINATION; DEATH; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HEART FAILURE; HEART MUSCLE REVASCULARIZATION; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL;

ACUTE CORONARY SYNDROME; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-18; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RECURRENCE; RISK ASSESSMENT; TIME FACTORS; TREATMENT OUTCOME; TROPONIN;

EID: 68049117232     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCA.0b013e32832e5c73     Document Type: Article

References (19)

1. Libby P, Ridker M, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105:1135-1143.
2. Armstrong EJ, Morrow DA, Sabatine MS. Inflammatory biomarkers in acute coronary syndromes. Part I: introduction and cytokines. Circulation 2006; 113:e72-e75.
3. Libby P. Current concepts of the pathogenesis of acute coronary syndromes. Circulation 2001; 104:365-372. (Pubitemid 32666962)
4. Mclnnes IB, Gracie JA, Leung BP, Wei X-Q, Liew F. Interleukin 18: a pleiotropic participant in chronic inflammation. Immunol Today 2000; 21:312-315. (Pubitemid 30428298)
5. Mallat K, Corbaz A, Scoazec A, Besnard S, Lesèche G, Chvatchko Y, Tedgui A. Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation 2001; 104:1598-1603. (Pubitemid 32947520)
6. Gerdes N, Sukhova G, Libby P, Reynolds RS, Young JL, Schö nbeck U. Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis. J Exp Med 2002; 195:245-257. (Pubitemid 34461268)
7. -/- mice through release of interferon-g. Circ Res 2002; 90:e34-e38.
8. Mallat K, Corbaz A, Scoazec A, Graber P, Alouani S, Esposito B, et al. Interleukin-18/interleukin-18 binding protein signaling modulates atherosclerotic lesion development and stability. Circ Res 2001; 89:e41-e45.
9. Chen M, Chen C, Yang C, Wu C-J, Fang C-Y, Hsieh Y-K, Chang H-W. Interleukin-18: a strong predictor of the extent of coronary artery disease in patients with unstable angina. Heart Vessels 2007; 22:371-375. (Pubitemid 350213857)
10. Mallat K, Henry P, Fressonnet R, Alouani S, Scoazec A, Beaufils P, et al. Increased plasma concentrations of interleukin-18 in acute coronary syndrome. Heart 2002; 88:467-469. (Pubitemid 35221955)
11. Chalikias GK, Tziakas DT, Kaski JC, Hatzinikolaou EI, Stakos DA, Tentes IK. Interleukin-18: interleukin-10 ratio and in-hospital adverse events in patients with acute coronary syndrome. Atherosclerosis 2005; 182:135-143.
12. Chalikias GK, Tziakas DT, Kaski JC, Kekes A, Hatzinikolaou EI, Stakos DA, et al. Interleukin-18/interleukin-10 ratio is an independent predictor of recurrent coronary events during a 1-year follow-up in patients with acute coronary syndrome. Int J Cardiol 2007; 117:333-339. (Pubitemid 46507625)
13. Blankenberg S, Tiret L, Bickel C, Peetz D, Cambien F, Meyer J, Rupprecht HJ. Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation 2002; 106:24-30. (Pubitemid 34747437)
14. Thygesen K, Joseph SA, Harvey DW. Universal definition of myocardial infarction. Task Force ESC/ACCF/AHA/WHF. Circulation 2007; 116:2634-2653.
15. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003; 107:499-511. (Pubitemid 36158056)
16. Tziakas DN, Chalikias GK, Kaski JC, Kekes A, Hatzinikolaou EI, Stakos DA, et al. Inflammatory and anti-inflammatory variable clusters and risk prediction in acute coronary syndrome patients: a factor analysis approach. Atherosclerosis 2007; 193:196-203. (Pubitemid 46776700)
17. Rosso R, Roth A, Herz I, Miller H, Keren G, George J. Serum levels of interleukin-18 in patients with stable and unstable angina pectoris. Int J Cardiol 2005; 98:45-48. (Pubitemid 40169851)
18. Jefferey AL, Adams CD, Antman EM. ACC/AHA Guidelines for the Management of Patients with Unstable Angina/Non-ST Elevation Myocardial Infarction. J Am Coll Cardiol 2007; 50:652-726.
19. Heeschen C, Dimmeler S, Hamm CW, Fichtlscherer S, Boersma E, Simoons ML, et al. Serum level of the antiinflamatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation 2003; 107:2109-2114. (Pubitemid 36532192)